omacetaxine (synribo) Report issue

Small molecule Orphan Drug FDA Approved FDA Fast Track FDA Accelerated Approval FDA

Active Ingredient History

  • Now
Cephalotaxine is an active metabolite of omacetaxine mepesuccinate also known as omacetaxine. In most patients the levels of cephalotaxine are undetectable. Omacetaxine mepesuccinate is a first-in-class cephalotaxine demonstrating clinical activity in chronic myeloid leukemia.   NCATS

  • SMILES: COC1=C[C@]23CCCN2CCC4=C(C=C5OCOC5=C4)[C@@H]3[C@@H]1O
  • Mol. Mass: 315.3636
  • ALogP: 2.58
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$96.0925 - $126.9500
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

(2'r,3s,4s,5r)-(−)-homoharringtonine | ceflatonin | cgx-635 | hht | homoharringtonin | homoharringtonine | (−)-homoharringtonine | homoharringtonine, 3h-labeled, (3(r))-isomer | nsc 141633 | nsc-141633 | omacetaxine | omacetaxine mepesuccinate | synribo


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue